About Moria Surgical
Moria Surgical is a company based in Antony (France) founded in 1820 was acquired by Naxicap in August 2019. Moria Surgical offers products and services including Speculum, Forceps, Capsulorhexis Forceps, Needle-holder, and Scissors. Moria Surgical operates in a competitive market with competitors including Bausch & Lomb, Lamellar, Dopavision, Katena and Appasamy Associates, among others.
- Headquarter Antony, France
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Moria Surgical
Moria Surgical offers a comprehensive portfolio of products and services, including Speculum, Forceps, Capsulorhexis Forceps, Needle-holder, and Scissors.
Device for holding eyelids open during ophthalmic procedures
Instrument for grasping tissues in eye surgeries
Tool for creating openings in the eye lens capsule
Device for holding needles during surgical operations
Cutting instrument for precise ophthalmic tissue dissection
People of Moria Surgical
Unlock access to complete
Funding Insights of Moria Surgical
Investors in Moria Surgical
Moria Surgical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Eurazeo, Bridgepoint Capital and Naxicap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and debt investments are managed across multiple sectors.
|
Locked | Locked | Locked | |
|
Middle-market businesses up to €1 billion are acquired pan-Europe.
|
Locked | Locked | Locked | |
|
Investments in small and medium-sized businesses are managed by Naxicap.
|
Locked | Locked | Locked |
Investor details for Moria Surgical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Moria Surgical
Investment portfolio details for Moria Surgical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Moria Surgical
Detailed financials for Moria Surgical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Moria Surgical Comparisons
Peer comparison for Moria Surgical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Moria Surgical
Moria Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bausch & Lomb, Lamellar, Dopavision, Katena and Appasamy Associates, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ophthalmic pharmaceuticals and instruments are developed for eye care.
|
|
| Locked | Locked | Locked |
Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies
|
|
| Locked | Locked | Locked |
Digital therapeutics for myopia are developed via retinal light stimulation.
|
|
| Locked | Locked | Locked |
Ophthalmic surgical instrument manufacturer
|
|
| Locked | Locked | Locked |
Ophthalmic instruments and pharmaceutical products are developed for eye care.
|
|
| Locked | Locked | Locked |
Developer of small aperture technology-based ophthalmic devices
|
Detailed competitors of Moria Surgical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Moria Surgical
Complete news archive for Moria Surgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Moria Surgical
Moria Surgical was founded in 1820 and raised its 1st funding round 204 years after it was founded.
Moria Surgical is headquartered in Antony, France. It is registered at Antony, Ile-de-france, France.
Bruno Chermette is the current CEO of Moria Surgical.
Moria Surgical designs and manufactures precision instrumentation and equipment for eye surgery. The company offers LASIK One Use-Plus SBK, LASIK M2 Single Use and Surface Ablation EPIK for Corneal Surgery; Endothelial Keratoplasty, Anterior Lamellar Keratoplasty and Penetrating Keratoplasty for a corneal transplant. Also provides single-use instruments for cataract surgery, and retinopathy of prematurity under the Moria ONE brand name; and a range of hand-held instruments for ophthalmic surgery. The company was taken private in November 2011. The original investment in Moria was made by Edmond de Rothschild Capital Partners in 2010, and is now managed by Bridgepoint Portfolio Services.
Moria Surgical's top competitors include Bausch & Lomb, Appasamy Associates and Katalyst Surgical.
Moria Surgical offers Speculum, Forceps, Capsulorhexis Forceps, Needle-holder, and Scissors.
Moria Surgical has 3 investors. Key investors include Eurazeo, Bridgepoint Capital, and Naxicap.